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Supplementary Figure 1. Structure-based sequence alignment 
of CAP210 with clade B gp120s with known 3-D structures
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Supplementary Fig. 1. Structure‐based sequence alignment of CAP210 and clade B gp120s with known 3‐D structures. The CAP210 sequence  is presented with differences  in the other gp120 sequences shown below. Gaps are designated with a dash. Locations of the V1‐V5 variable loops are indicated above the sequence. Deletions to remove the V1V2 and V3 loops are denoted with lowercase  letters. α‐helices  and  β‐strands  are  denoted  with  spirals  and  arrows,  respectively. Regions that are disordered in the CAP210 structure are indicated above its sequence with the letter  “d”.  CAP210  residues  that  contact  both  sCD4  and  21c  are  shown  in  blue,  residues  that contact only sCD4 are in green, and residues that contact only 21c are in red. Potential N‐linked glycosylation sites  in CAP210 are  indicated with a green asterisk above the asparagines  in the Asn‐X‐Ser/Thr motif. Residues that were mutated in CAP210 to eliminate N‐linked carbohydrate sites are bold. 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Supplementary Figure 2. Sequence of the heavy 
and light chains of the 21c Fab
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Supplementary Fig. 2.   Sequence of the heavy and light chains of the 21c Fab. Variable regions sequences are red; constant regions are black. Arrows denote and name the β‐strands in the four domains (VH, CH1, VL, CL) of  the Fab. Complementarity regions (CDRs) on the heavy chain (H1, H2,  H3)  and  the  light  chain  (L1,  L2,  L3)  variable  regions  are  indicated  above  the  sequence. Residues  that  contact  gp120  are  in  red boxes,  contacts with  sCD4  are  blue,  and  residues  that contact both gp120 and sCD4 are green. Differences between mature 21c and germline variable regions are  listed below each sequence. The 21c  light chain was derived  from the germline VL IGLV1‐51*01 and J IGLJ2*01 gene segments, respectively (analyzed using IMGT1). One difference between  the  germline  and mature VL  sequences  is  the  substitution of  asparagine  for  lysine  at position  32,  which  is  located  at  the  interface  with  sCD4.  The  21c  heavy  chain  sequence  is  a descendent  of  the  IGHV1‐24*01  VH  gene  segment  in  common  with  other  known  CD4i antibodies2. The D and J gene segments were derived from IGHJ4*02 and IGHD3‐3*01. 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Supplementary Fig.  3. Close‐up views of  interaction  interfaces.  (a) Left:  Interface between  the 21c heavy chain (pink ribbons with highlighted sidechains) and CAP210 (transparent surface). Right:  Electron  density  (σ  =  2.0)  from  a  Fo‐Fc  omit map  highlighting  the  interaction  between CAP210  Arg431  and  21c  heavy  chain  residue  Glu55.  Although  some  CD4i  antibodies  include sulfated  tyrosines  in  their  heavy  chain  H3  loop  that  mimic  sulfation  on  CCR53, Western  blot analyses using an anti‐sulfotyrosine antibody (Millipore) did not detect tyrosine sulfation of the 21c heavy chain on blots in which sulfation was detected for other CD4i antibodies (E51, 412d) (Yunji Wu, R.D., and P.J.B., unpublished results). In 21c, the H2 mainchain near Asn56 occupies the corresponding volume as Tyr100, a sulfated tyrosine in the H3 loop of 412d, which interacts with  a  polar  pocket  on  gp1203.  (b)  Interface  between  21c  (yellow  and  pink with  highlighted sidechains) and sCD4 (transparent surface). 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Supplementary  Fig.  4.  Comparison  of  free  and  bound  21c.  (a)  Stereo  superposition  of  the structures  of  21c  alone  (red)  and  21c  complexed  with  CAP210  and  sCD4  (blue).  The  VH‐VL domains  were  superimposed,  demonstrating  the  large  movement  of  the  CH1‐CL  domains (indicated  with  an  arrow).  (b)  Close‐up  of  the  21c  combining  site  in  its  free  and  bound conformations.    Changes  in  the  H3  and  H2  loops  allow  Leu105  (H3)  and  Glu55  (H2) (highlighted) to fit into their respective pockets on the surface of gp120. 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Supplementary Fig. 5. Characterization of sCD4K75T. Sensorgrams from SPR experiments in which a concentration series (from 1.0 µM to 31.2 nM, two‐fold dilutions) of the indicated clade  C  core  gp120  protein  was  injected  together  with  2.0  µM  sCD4  or  sCD4K75T  over immobilized  21c  Fab.  (a‐b)  Sensorgrams  presented  in  Fig.  5  are  shown  separately  with residual plots for fitted curves. (c) Analysis of additional core clade C gp120 proteins. 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